Using What You've Got
Serotonin-Activated Kinase Can Fight Amyloid Plaques
By Anette Breindl
Wednesday, August 24, 2011
The road to developing Alzheimer's drugs has been littered with disappointments. But this week, researchers from Washington University in St. Louis published data suggesting that another class of drugs may be useful in preventing the formation of amyloid plaques: antidepressants that work via selective serotonin reuptake inhibition (SSRI).
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.